Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency

Although it is estimated that COVID-19 life-threatening conditions may be diagnosed in less than 1:1000 infected individuals below the age of 50, but the real impact of this pandemic on pediatric patients with different types of primary immunodeficiency (PID) is not elucidated. The current prospecti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Immunol
Auteurs principaux: Delavari, Samaneh, Abolhassani, Hassan, Abolnezhadian, Farhad, Babaha, Fateme, Iranparast, Sara, Ahanchian, Hamid, Moazzen, Nasrin, Nabavi, Mohammad, Arshi, Saba, Fallahpour, Morteza, Bemanian, Mohammad Hassan, Shokri, Sima, Momen, Tooba, Sadeghi-Shabestari, Mahnaz, Molatefi, Rasol, Shirkani, Afshin, Vosughimotlagh, Ahmad, Safarirad, Molood, Sharifzadeh, Meisam, Pashangzadeh, Salar, Salami, Fereshte, Shirmast, Paniz, Rezaei, Arezou, Moeini Shad, Tannaz, Mohraz, Minoo, Rezaei, Nima, Hammarström, Lennart, Yazdani, Reza, Aghamohamamdi, Asghar
Format: Artigo
Langue:Inglês
Publié: Springer US 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7707812/
https://ncbi.nlm.nih.gov/pubmed/33263173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-020-00928-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires